首页> 外国专利> A method of predicting outcomes flow necrotizing enterocolitis in newborn infants

A method of predicting outcomes flow necrotizing enterocolitis in newborn infants

机译:预测新生儿坏死性小肠结肠炎血流的方法

摘要

A method for predicting the outcome of treatment in neonates with necrotizing enterocolitis, using regression analysis, characterized in that during the execution of the process is determined characteristic leukocyte formula (X1), evaluated the presence or absence of a lesion of the respiratory system (X2), the serum level (ng / ml) of matrix metalloproteinase 2 type (X3), calprotectin concentration (ug / g) in the feces (X4), the serum level (ng / ml) inhibitor of matrix metalloproteinase 9 type (X5), the scale value sc Enki gravity multiple organ disorders in SOFA scores (X6), then determine the prognosis results of treatment of necrotizing enterocolitis in newborn formula: d = -7,148 + X1 · (0,915) + X2 · -0,292 + X3 · 0,005 + X4 · 0,002 + X5 · 0,001 + X6 · 0,201, wherein X - the numerical value for a particular patient, and the patient can be attributed to the group of survivors in the distribution of values ​​of group centroid in the range from 0 to -1.258, and group centroids at values ​​ranging from 0 to 2,124 patient can refer to a group with a high probability of death.
机译:一种使用回归分析预测新生儿坏死性小肠结肠炎的治疗结果的方法,其特征在于,在执行该过程期间确定特征性白细胞公式(X1),评估呼吸系统是否存在病变(X2) ),血清中基质金属蛋白酶2型(X3)的水平(ng / ml),粪便中钙卫蛋白浓度(ug / g)(X4),基质金属蛋白酶9型抑制剂的血清水平(ng / ml)(X5) ,将SC值的Enki重力多器官功能障碍评分在SOFA中得分(X6),然后确定新生儿坏死性小肠结肠炎的治疗预后结果:d = -7,148 + X1·(0,915)+ X2·-0,292 + X3·0,005 + X4·0,002 + X5·0,001 + X6·0,201,其中X-特定患者的数值,并且该患者可以归类为幸存者组,其质心组的值分布范围从0开始到-1.258,并在值范围从0到2,124的患者可以指死亡可能性很高的人群。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号